207 related articles for article (PubMed ID: 29653287)
1. Detecting the functional complexities between high-density lipoprotein mimetics.
Sei YJ; Ahn J; Kim T; Shin E; Santiago-Lopez AJ; Jang SS; Jeon NL; Jang YC; Kim Y
Biomaterials; 2018 Jul; 170():58-69. PubMed ID: 29653287
[TBL] [Abstract][Full Text] [Related]
2. Engineered biomimetic nanoparticle for dual targeting of the cancer stem-like cell population in sonic hedgehog medulloblastoma.
Kim J; Dey A; Malhotra A; Liu J; Ahn SI; Sei YJ; Kenney AM; MacDonald TJ; Kim Y
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24205-24212. PubMed ID: 32934143
[TBL] [Abstract][Full Text] [Related]
3. HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages.
Sanchez-Gaytan BL; Fay F; Lobatto ME; Tang J; Ouimet M; Kim Y; van der Staay SE; van Rijs SM; Priem B; Zhang L; Fisher EA; Moore KJ; Langer R; Fayad ZA; Mulder WJ
Bioconjug Chem; 2015 Mar; 26(3):443-51. PubMed ID: 25650634
[TBL] [Abstract][Full Text] [Related]
4. Distinct Roles of Apolipoproteins A1 and E in the Modulation of High-Density Lipoprotein Composition and Function.
Filou S; Lhomme M; Karavia EA; Kalogeropoulou C; Theodoropoulos V; Zvintzou E; Sakellaropoulos GC; Petropoulou PI; Constantinou C; Kontush A; Kypreos KE
Biochemistry; 2016 Jul; 55(27):3752-62. PubMed ID: 27332083
[TBL] [Abstract][Full Text] [Related]
5. A novel anti-inflammatory mechanism of high density lipoprotein through up-regulating annexin A1 in vascular endothelial cells.
Pan B; Kong J; Jin J; Kong J; He Y; Dong S; Ji L; Liu D; He D; Kong L; Jin DK; Willard B; Pennathur S; Zheng L
Biochim Biophys Acta; 2016 Jun; 1861(6):501-12. PubMed ID: 27012521
[TBL] [Abstract][Full Text] [Related]
6. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.
Durham KK; Chathely KM; Mak KC; Momen A; Thomas CT; Zhao YY; MacDonald ME; Curtis JM; Husain M; Trigatti BL
Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H31-H44. PubMed ID: 28986362
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1.
Fung KYY; Ho TWW; Xu Z; Neculai D; Beauchemin CAA; Lee WL; Fairn GD
J Lipid Res; 2024 Apr; 65(4):100530. PubMed ID: 38479648
[TBL] [Abstract][Full Text] [Related]
8. Highly conserved amino acid residues in apolipoprotein A1 discordantly induce high density lipoprotein assembly in vitro and in vivo.
Yelamanchili D; Liu J; Gotto AM; Hurley AE; Lagor WR; Gillard BK; Davidson WS; Pownall HJ; Rosales C
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158794. PubMed ID: 32810603
[TBL] [Abstract][Full Text] [Related]
9. Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research.
Kornmueller K; Vidakovic I; Prassl R
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382521
[TBL] [Abstract][Full Text] [Related]
10. The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects.
Zamanian-Daryoush M; Lindner D; Tallant TC; Wang Z; Buffa J; Klipfell E; Parker Y; Hatala D; Parsons-Wingerter P; Rayman P; Yusufishaq MSS; Fisher EA; Smith JD; Finke J; DiDonato JA; Hazen SL
J Biol Chem; 2013 Jul; 288(29):21237-21252. PubMed ID: 23720750
[TBL] [Abstract][Full Text] [Related]
11. PI(4,5)P2 Is Translocated by ABCA1 to the Cell Surface Where It Mediates Apolipoprotein A1 Binding and Nascent HDL Assembly.
Gulshan K; Brubaker G; Conger H; Wang S; Zhang R; Hazen SL; Smith JD
Circ Res; 2016 Sep; 119(7):827-38. PubMed ID: 27514935
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A1 Forms 5/5 and 5/4 Antiparallel Dimers in Human High-density Lipoprotein.
He Y; Song HD; Anantharamaiah GM; Palgunachari MN; Bornfeldt KE; Segrest JP; Heinecke JW
Mol Cell Proteomics; 2019 May; 18(5):854-864. PubMed ID: 30659061
[TBL] [Abstract][Full Text] [Related]
13. Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles.
Zheng Y; Liu Y; Jin H; Pan S; Qian Y; Huang C; Zeng Y; Luo Q; Zeng M; Zhang Z
Theranostics; 2013; 3(7):477-86. PubMed ID: 23843895
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1.
He D; Zhao M; Wu C; Zhang W; Niu C; Yu B; Jin J; Ji L; Willard B; Mathew AV; Chen YE; Pennathur S; Yin H; He Y; Pan B; Zheng L
Redox Biol; 2018 May; 15():228-242. PubMed ID: 29277016
[TBL] [Abstract][Full Text] [Related]
15. Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma.
DiDonato JA; Huang Y; Aulak KS; Even-Or O; Gerstenecker G; Gogonea V; Wu Y; Fox PL; Tang WH; Plow EF; Smith JD; Fisher EA; Hazen SL
Circulation; 2013 Oct; 128(15):1644-55. PubMed ID: 23969698
[TBL] [Abstract][Full Text] [Related]
16. Reduced glutathione increases quercetin stimulatory effects on HDL- or apoA1-mediated cholesterol efflux from J774A.1 macrophages.
Rosenblat M; Volkova N; Khatib S; Mahmood S; Vaya J; Aviram M
Free Radic Res; 2014 Dec; 48(12):1462-72. PubMed ID: 25204422
[TBL] [Abstract][Full Text] [Related]
17. Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.
Xepapadaki E; Maulucci G; Constantinou C; Karavia EA; Zvintzou E; Daniel B; Sasson S; Kypreos KE
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1351-1360. PubMed ID: 30742993
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of the F
Cabou C; Honorato P; Briceño L; Ghezali L; Duparc T; León M; Combes G; Frayssinhes L; Fournel A; Abot A; Masri B; Parada N; Aguilera V; Aguayo C; Knauf C; González M; Radojkovic C; Martinez LO
Acta Physiol (Oxf); 2019 Jul; 226(3):e13268. PubMed ID: 30821416
[TBL] [Abstract][Full Text] [Related]
19. Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner.
Durham KK; Kluck G; Mak KC; Deng YD; Trigatti BL
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1447-H1457. PubMed ID: 31002281
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis.
Sherman CB; Peterson SJ; Frishman WH
Cardiol Rev; 2010; 18(3):141-7. PubMed ID: 20395699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
